Table 1 Baseline Demographic and Clinical Characteristics
|  | Population Sample (N = 36) | |
|---|---|---|
Missing, n | Patients | |
Sex, n (%) | 0 | Â |
 Male |  | 12.0 (33.3) |
 Female |  | 24.0 (66.7) |
Age, years | 1 | Â |
 Mean (SD) |  | 36.3 (13.2) |
 Median (range) |  | 35.5 (0a–70) |
Race, n (%) | 0 | Â |
 American Indian or Alaska Native |  | 0 |
 Asian |  | 1 (2.8) |
 Black or African American |  | 1 (2.8) |
 Native Hawaiian or other Pacific Islander |  | 0 |
 White |  | 34 (94.4) |
Employment/educational status, n (%) | 0 | Â |
 Employed (full time or part time) |  | 23 (3.9) |
 School (full time or part time) |  | 2 (5.6) |
 Unemployed |  | 4 (11.1) |
 Retired |  | 2 (5.6) |
 Disabled |  | 3 (8.3) |
 Other |  | 2 (5.6) |
Clinician-reported cTTP severity, n (%) | 13 | Â |
 Normal |  | 0 |
 Mild |  | 13 (56.5) |
 Moderate |  | 8 (34.8) |
 Severe |  | 2 (8.7) |
Any comorbidities, n (%) | 13 | Â |
 No |  | 18 (78.3) |
 Yes |  | 5 (21.7) |
Number of comorbidities, n (%) | 13 | Â |
 0 |  | 18 (78.3) |
 1 |  | 3 (13.0) |
 2 |  | 1 (4.3) |
 3 |  | 0 |
 4 |  | 1 (4.3) |
cTTP treatment history (treatment was received), n (%) | 23 | Â |
 Periodically |  | 9 (69.2) |
 As needed |  | 4 (30.8) |
cTTP treatment type, n (%) | 0 | Â |
 Fresh frozen plasma |  | 16 (44.4) |
 Solvent detergent plasma |  | 13 (36.1) |
 VWF/FVIII concentrate |  | 6 (16.7) |
 Unknown |  | 1 (2.8) |
cTTP treatment, n (%) | 0 | Â |
 Prophylactic |  | 28 (77.8) |
 On-demand |  | 8 (22.2) |